» Articles » PMID: 38233635

Hypothalamic-Pituitary-Adrenal Axis Suppression with Inhaled Corticosteroids-Time to Close the Debate?

Overview
Specialty Pediatrics
Date 2024 Jan 17
PMID 38233635
Authors
Affiliations
Soon will be listed here.
References
1.
Asher M, Rutter C, Bissell K, Chiang C, El Sony A, Ellwood E . Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021; 398(10311):1569-1580. PMC: 8573635. DOI: 10.1016/S0140-6736(21)01450-1. View

2.
Lipworth B . Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999; 159(9):941-55. DOI: 10.1001/archinte.159.9.941. View

3.
Kwda A, Gldc P, Baui B, Kasr K, Us H, S W . Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma. BMC Pediatr. 2019; 19(1):411. PMC: 6829958. DOI: 10.1186/s12887-019-1760-8. View

4.
Hema L, Kumar P, Goyal J, Vyas V, Singh K . Effect of Long-term Inhaled Corticosteroids on the Hypothalamic-Pituitary-Adrenal Axis in Children with Asthma. Indian J Pediatr. 2023; 91(5):441-447. DOI: 10.1007/s12098-023-04706-6. View

5.
Casale T, Nelson H, Stricker W, Raff H, Newman K . Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001; 87(5):379-85. DOI: 10.1016/S1081-1206(10)62918-3. View